The calibration corpus is not accessible due to infrastructure issues (persistent "No such file or directory" errors). I will proceed with scoring based on my analysis of the paper against the ICLR review guidelines.

Let me finalize the review.

---

## Summary
HYPOGENEAGENT proposes an LLM-driven framework that uses GO-based hypotheses from a gene-set analysis agent to score clustering resolutions via intra-cluster agreement (ICS) and inter-cluster distinctiveness (ICD), thereby turning subjective resolution tuning into a quantifiable optimization problem. The method is evaluated on a K562 Perturb-seq dataset, where the Resolution Score selects resolutions different from those chosen by silhouette and modularity.

## Strengths

1. **Novel closed-loop framework connecting functional annotation to resolution selection.** The paper is the first to define a quantitative Resolution Score that takes LLM-generated GO hypotheses and uses their intra-cluster agreement and inter-cluster distinctiveness to select clustering resolution — bridging unsupervised clustering with biology-aware optimization. Prior works (GeneAgent, Hu et al., Wu et al.) operate on already-fixed clusters without feeding functional feedback back into clustering hyperparameters. (Section 2, Section 3.4)

2. **Systematic ablation of the LLM pipeline's design space on 100 curated GOBP gene sets.** Stage 1 (Section 4.3) evaluates three embedding methods (OpenAI text-embedding-3-large, SapBERT, Nomic AI), two prompt classes with two versions, temperature sensitivity (range [0,1], step 0.1, 3 repeats), five LLM backends (GPT-4o, GPT-o3, GPT-5, Gemini-2.0-flash, Gemini-2.5-pro), and validates that the LLM's self-ranked confidence correlates with ground-truth semantic similarity (top-1 candidate has highest median cosine similarity, AUC = 0.743 for GPT-o3 at threshold 0.40). This is a multi-faceted characterization, not a single-point evaluation.

3. **Clean formalization of ICS, ICD, and Resolution Score.** The metric definitions (Section 3.4, Table 1) are clear, mathematically well-specified, and provide a principled way to combine internal coherence and external separation into a single score. The decomposition into intra-cluster agreement and inter-cluster distinctiveness is conceptually sound.

## Weaknesses

### Fatal
None.

### Major

1. **The core claim of biologically superior resolution selection lacks a ground-truth anchor.** The paper shows that HYPOGENEAGENT selects resolution 0.4 (GEX) and 0.5 (perturbation), silhouette selects 0.5–0.6, and modularity selects 0.7 (Figures 3–5). However, there is no external benchmark or labeled ground truth establishing that 0.4/0.5 is objectively the "correct" or "biologically better" resolution. The functional enrichment comparison (Section 4.4.3) was intended as validation, but the enrichment-based Resolution Score actually peaks at 0.7 (Fig. 6a), not at 0.4 or 0.5. The paper attempts to reconcile this by saying "consider the reasonability of cluster numbers we expected, so the selected resolution can be 0.5 or 0.4" — but this introduces a different qualitative criterion ("reasonability") that is not defined or quantified, and does not resolve the discrepancy between the enrichment-based peak at 0.7 and the LLM-based peak at 0.4/0.5. Without an objective yardstick (e.g., measuring whether known perturbation-pathway pairs map to distinct clusters at specific resolutions), the claim that the LLM-based score selects biologically superior resolutions over classical metrics is not empirically substantiated.

2. **Inter-cluster distinctiveness (ICD) may conflate genuine biological separation with trivial input variation.** ICD measures cosine similarity between the top LLM-generated hypotheses of different clusters. However, the LLM receives different marker-gene lists for each cluster. By construction, different inputs will tend to produce different outputs; thus a low ICD (high distinctiveness) could simply reflect that the LLM was given different gene lists, regardless of whether the clustering is biologically meaningful. The paper provides no control experiment (e.g., randomized gene-to-cluster assignments, synthetic permuted signatures) to demonstrate that ICD behaves differently for meaningful vs. meaningless partitions. This weakens the claim that ICD captures genuine biological distinctiveness rather than a trivial property of the LLM input-output mapping. (Section 3.4)

### Minor

3. **Resolution score stability across stochastic LLM runs is not demonstrated for Stage 2.** Temperature and repeatability are tested in Stage 1 (on GPT-4o with the general prompt, Section 4.3), but no repeated runs are reported for the Stage 2 resolution selection (GPT-o3 with the hypothesis prompt, Section 4.4), which is the core result. Since the method relies on LLM outputs that are stochastic (temperature > 0 is used in Stage 1 exploration), the reader cannot assess whether the optimal resolution (0.4 or 0.5) is robust across multiple LLM calls or is a product of stochastic variation.

4. **The weight parameter w=1/3 is under-justified for the main resolution selection claim.** The paper states that w=1/3 was "chosen by a small grid search" and Figure S5 analyzes w sensitivity (Section 3.4). However, the main text does not report whether the optimal resolution *ranking* changes with w. If the optimal resolution shifts when w is varied within a reasonable range (e.g., 0.2–0.5), then the method is not providing an objective answer — it is encoding the user's choice of w.

5. **The enrichment-based validation (Section 4.4.3) partially undermines rather than confirms the main result.** The enrichment-based Resolution Score (applying the same ICS/ICD metrics to enrichment p-values) peaks at resolution 0.7 (Fig. 6a), not at 0.4 or 0.5 selected by HYPOGENEAGENT. The paper's attempt to reconcile this by invoking "reasonability of cluster numbers" introduces a post-hoc qualitative judgment that undercuts the claim that the Resolution Score provides an objective, data-driven optimization.

6. **No practical cost or throughput characterization.** The paper acknowledges "LLM dependence and cost" in the limitations (Section 5) but does not report the number of LLM API calls, tokens consumed, or approximate dollar cost for the Perturb-seq analysis. For practical deployment, the community needs to know whether this pipeline is economically feasible.

### Trivial

7. Section 3.2 ("Clustering Procedure") is three sentences long and defers essentially all detail to the appendix, making the main text non-self-contained even at a sketch level.

## Nice-to-Haves
- Comparison with MultiK (cited in Related Work but not used as a baseline), which is a resolution-selection tool specifically designed for single-cell data.
- Analysis of how the number of marker genes per cluster affects the Resolution Score.
- Control experiment showing ICD behavior on permuted vs. real cluster assignments (echoing Major Weakness #2, now as a concrete actionable experiment).

## Removed Points

These were filtered by the cross-check rules:

- **"Stage 1 validation only tests on curated clean gene sets"** → Scope creep. Stage 1 is explicitly a benchmark of LLM annotation ability, not a robustness-to-noise test. The paper does not claim otherwise.
- **"No justification for using median rather than mean"** → The paper provides the heuristic ("highest median score"). Both aggregators are reasonable; this is not a substantive weakness.
- **"UMAP validation is circular"** → UMAP is used only for visualization of the selected resolution, not as evidence for correctness. This is standard practice.
- **"No discussion of what calibration means (softmax vs logits)"** → Not relevant to the core contribution; calibration is a standard concept.
- **"Grammatical incompleteness"** → Parser artifact; the original submission does not have this issue.
- **"Section 3.2 is too brief to be reproducible even with the appendix"** → The paper explicitly refers to the appendix. Per removal rules, appendix content stripped by the parser is assumed to exist in the original submission.
- **Missing related works** → Cannot be verified; per removal rules, do not mention missing related works.
- **Generic strengths from Strength Finder** (e.g., "this paper addressed an important problem") → Removed as generic/superficial.
- **Strength about w being explicitly tuned** → Partially conflicts with Weakness #4; the sensitivity analysis is mentioned but the main text does not show whether the optimal resolution ranking changes with w. Only the weakness version is retained.
- **Reproducibility criticism about undisclosed hyperparameters** → The paper discloses the key hyperparameters (w=1/3, temperature range, prompt versions, embedding models).

## Novel Insights
None beyond the paper's own contributions.

## Suggestions
1. **Add an objective evaluation anchor:** On the K562 Perturb-seq data, identify known perturbation-pathway pairs (e.g., ribosomal perturbations → ribosome biogenesis cluster) and measure whether clusters at different resolutions correctly separate these pathways. This would provide a ground-truth-based comparison between the Resolution Score, silhouette, and modularity.
2. **Control experiment for ICD:** Randomize gene-to-cluster assignments or use permuted gene sets and demonstrate that ICD behaves differently (e.g., all clusters receive similar annotations) compared to the real clustering, showing that ICD captures genuine biological signal.
3. **Report stability:** Run the full Stage 2 pipeline 3–5 times and report whether the optimal resolution (0.4 or 0.5) is stable across runs.
4. **Report w-sensitivity of the resolution ranking:** Show the optimal resolution for w ∈ [0,1] and explicitly state the range of w over which the ranking is stable.
5. **Quantify cost:** Report the number of LLM API calls, total tokens, and approximate USD cost for processing the full Perturb-seq dataset.

---

**MY FINAL SCORE:** <score>5</score>
**MY FINAL DECISION:** <decision>Reject</decision>